ELISA / EIA / RIA Kits · ELISA / EIA kit · Cat. EK-028-11
GLP-1 (7-36) amide (Human, Rat, Mouse, Porcine, Bovine, Canine, Ovine) – EIA Kit
Supplied as 96 wells per unit. Species: Bovine, Canine, Human, Mouse, Ovine, Porcine, Rat. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | EK-028-11 |
|---|---|
| Product type | ELISA / EIA / RIA Kits · ELISA / EIA kit |
| Peptide family | Glucagon-Like Peptide-1 (GLP-1) |
| Species | Bovine, Canine, Human, Mouse, Ovine, Porcine, Rat |
| Unit size | 96 wells |
| Sensitivity | 0.11 ng/ml |
| Specificity | Peptide % GLP-1 (7-36) (Human, Rat, Mouse) 100 GLP-1 (9-36) Amide 100 GLP-1 (1-36) Amide (Human) 100 GLP-1 (7-37) (Human, Rat, Mouse) 0.4 GLP-2 (Human) 0 Glucagon (Human, Rat, Mouse, Porcine, Bovine) 0 CGRP 0 GIP 0 VIP 0 Insulin 0 0 Exendin-4 0 |
| Linear Range | 0.11 - 1.09 ng/ml |
| Inter-Assay CV | <15% |
| Intra-Assay CV | <10% |
| Standard Curve | Contact us for technical specifications on this product. Expression of genes related to energy metabolism (osteocalcin, FOXO1, insulin receptor, and SOST) in bone cells of Goto-Kakizaki rats and response to bariatric surgery. Pérez-castrillón JL, Riancho JA, De luis D, Gonzalez-sagrado M, Domingo-andres M, Dueñas-laita A. Surg Obes Relat Dis. 2014;10(2):299-303. Long-term inhibition of intestinal lipase by orlistat improves release of gut hormones increasing satiety in obese women. Olszanecka-glinianowicz M, D?browski P, Koce?ak P, et al. Pharmacol Rep. 2013;65(3):666-71. Effect of two types of bariatric surgery (gastrojejunal bypass and sleeve gastroplasty) on gene expression of bone remodeling markers in Goto-Kakizaki rats. Pérez-castrillón JL, Riancho JA, De luis D, et al. Obes Surg. 2014;24(1):37-41. Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. Mencarelli A, Renga B, D'amore C, et al. Diabetes. 2013;62(10):3384-93. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. Drafts BC, Twomley KM, D'agostino R, et al. JACC Cardiovasc Imaging. 2013;6(8):877-85. GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects. Fernández-garcía JC, Murri M, Coin-aragüez L, Alcaide J, El bekay R, Tinahones FJ. Clin Endocrinol (Oxf). 2014;80(5):671-6. Basal glucagonlike peptide 1 levels and metabolic syndrome in obese patients. De luis DA, Aller R, Conde R, et al. J Investig Med. 2012;60(6):874-7. The deleterious effect of bariatric surgery on cortical and trabecular bone density in the femurs of non-obese, type 2 diabetic Goto-Kakizaki rats. Pérez-castrillón JL, Riancho JA, De luis D, et al. Obes Surg. 2012;22(11):1755-60. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Yamaoka-tojo M, Tojo T, Takahira N, et al. Cardiovasc Diabetol. 2010;9:17. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Granata R, Settanni F, Gallo D, et al. Diabetes. 2008;57(4):967-79. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Santoro S, Milleo FQ, Malzoni CE, et al. Obes Surg. 2008;18(1):17-26. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Pacheco D, De luis DA, Romero A, et al. Am J Surg. 2007;194(2):221-4. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Suzuki S, Ramos EJ, Goncalves CG, Chen C, Meguid MM. Surgery. 2005;138(2):283-90. |
| Sample Extraction | Recommended |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Frequently asked
What is GLP-1 (7-36) amide (Human, Rat, Mouse, Porcine, Bovine, Canine, Ovine) – EIA Kit?
GLP-1 (7-36) amide (Human, Rat, Mouse, Porcine, Bovine, Canine, Ovine) – EIA Kit is a elisa / eia kit elisa / eia / ria kit listed under catalog number EK-028-11 in the Glucagon-Like Peptide-1 (GLP-1) family, bovine / canine / human / mouse / ovine / porcine / rat sequence. It is supplied as 96 wells per unit for in vitro laboratory research.
What is the intended use of EK-028-11?
This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.